High Court Declines Review Of Stock-Drop Suit Against Drug Maker, Others

Mealey's (May 20, 2019, 1:12 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on May 20 declined to review a Ninth Circuit U.S. Court of Appeals panel’s ruling that a federal district court abused its discretion in granting judicial notice on a series of documents before granting a motion to dismiss filed by a pharmaceutical company and certain of its senior executives in a securities class action lawsuit (Joseph P. Hagan, et al. v. Karim Khoja, No. 18-1010, U.S. Sup.)....